Cite
MLA Citation
Robert Croop et al.. “Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial.” Lancet, vol. 397, no. 10268, 2021, pp. 51–60. http://access.bl.uk/ark:/81055/vdc_100118542039.0x00005c